Scholarlink

<p>To quantify the prevalence of HIV testing indications among hospitalised adults in Türkiye, assess HIV testing coverage when clinically indicated, and identify missed diagnostic opportunities in a national multicentre point-prevalence survey. We conducted a national multicentre cross-sectional point-prevalence survey across tertiary referral hospitals from all seven geographical regions of Türkiye. Adult inpatients present at 08:00 on a predefined index day were assessed for predefined HIV testing indications, including AIDS-defining conditions, indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and conditions in which unrecognised HIV could substantially affect clinical management. Among 3,425 hospitalised adults without known HIV infection, 699 (20.4%) had at least one documented HIV testing indication. HIV testing was requested by the primary clinical team in 424/699 patients (60.7%). Testing was lowest in patients with indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and these conditions were independently associated with higher odds of non-performance of HIV testing by the primary clinical team than AIDS-defining conditions (corresponding adjusted odds ratio [aOR] 3.05, 95% confidence interval [CI] 1.67–5.81). In centres with a specialised HIV outpatient clinic, the odds of non-performance of HIV testing by the primary clinical team were independently lower among patients with an appropriate testing indication (corresponding aOR 0.64, 95% CI 0.43–0.95). Following study-team facilitation, overall testing coverage increased to 677/699 (96.9%). Three reactive screening results were identified, including two confirmed new HIV diagnoses. HIV testing indications were common among hospitalised adults in Türkiye, but non-performance of HIV testing by the primary clinical team remained frequent, particularly for non-AIDS indicator conditions. Strengthening indicator-condition-guided testing through structured clinical pathways and institutional HIV expertise may reduce non-performance and support earlier HIV diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Missed opportunities for HIV testing in hospitalised adults in türkiye: ındicator conditions and testing coverage in a national multicentre point-prevalence survey (HIV-ICs-TR)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月30日

查看全文
  • Yeliz Çiçek,
  • Mustafa Kemal Çelen,
  • Hüsnü Pullukçu,
  • Seyit Ali Büyüktuna,
  • Fatma Kesmez Can,
  • Damla Ertürk,
  • Buket Erturk Sengel,
  • Hanife Nur Karakoc Parlayan,
  • İlknur Esen Yıldız,
  • Kemalettin Özden,
  • Handan Alay,
  • Ayşe Albayrak,
  • Duygu Aran Seçkin,
  • Galip Erdoğan,
  • Tajdin İrdem,
  • Betül Seçen Gülçek,
  • Kübra Okul,
  • Derya Kaya,
  • Cansu Tol,
  • Mehmet Buğra Özkara,
  • Meltem Ceylan,
  • Oğuzhan Acet,
  • Caner Öksüz,
  • Rıdvan Karaarslan,
  • Zülal Peri Yoldaş Aslanoğlu,
  • Esra İrem Dağcı,
  • Süheyla Kömür,
  • Sümeyra Demir,
  • Ömer Faruk Yardımcı,
  • Gökçe Melis Çolak,
  • Diana Zakaradze,
  • Esma Demir Kalyoncu,
  • Betul Ocak,
  • Gürdal Yılmaz,
  • Ahmet Turan Koç,
  • Adem Kaya,
  • Maşite Nur Özdemir,
  • Gülter Öncü Kurutaş,
  • Tuba İlgar,
  • Aybegüm Özşahin,
  • Sudem Mahmutoğlu-Çolak,
  • Kenan Beşbaş,
  • Yeşim Taşova

摘要

To quantify the prevalence of HIV testing indications among hospitalised adults in Türkiye, assess HIV testing coverage when clinically indicated, and identify missed diagnostic opportunities in a national multicentre point-prevalence survey. We conducted a national multicentre cross-sectional point-prevalence survey across tertiary referral hospitals from all seven geographical regions of Türkiye. Adult inpatients present at 08:00 on a predefined index day were assessed for predefined HIV testing indications, including AIDS-defining conditions, indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and conditions in which unrecognised HIV could substantially affect clinical management. Among 3,425 hospitalised adults without known HIV infection, 699 (20.4%) had at least one documented HIV testing indication. HIV testing was requested by the primary clinical team in 424/699 patients (60.7%). Testing was lowest in patients with indicator conditions associated with an expected undiagnosed HIV prevalence ≥ 0.1%, and these conditions were independently associated with higher odds of non-performance of HIV testing by the primary clinical team than AIDS-defining conditions (corresponding adjusted odds ratio [aOR] 3.05, 95% confidence interval [CI] 1.67–5.81). In centres with a specialised HIV outpatient clinic, the odds of non-performance of HIV testing by the primary clinical team were independently lower among patients with an appropriate testing indication (corresponding aOR 0.64, 95% CI 0.43–0.95). Following study-team facilitation, overall testing coverage increased to 677/699 (96.9%). Three reactive screening results were identified, including two confirmed new HIV diagnoses. HIV testing indications were common among hospitalised adults in Türkiye, but non-performance of HIV testing by the primary clinical team remained frequent, particularly for non-AIDS indicator conditions. Strengthening indicator-condition-guided testing through structured clinical pathways and institutional HIV expertise may reduce non-performance and support earlier HIV diagnosis.